Dr. Matthew J. Higgins joined the strategic management faculty in 2005. His research interests center primarily on firm responses to productivity changes (and challenges) and the performance implications of these decisions. This includes understanding the interrelationship between internal R&D and the use of external technology markets through acquisitions, alliances, licensing and corporate venture capital. He is also interested in the impact regulation has on innovation and productivity. Most of Dr. Higgins' research has been conducted within the context of the pharmaceutical industry and has been accepted for publication in a diverse range of leading journals including Science, Journal of Financial Economics, Review of Economics and Statistics and Strategic Management Journal.
Dr. Higgins was the recipient of a National Science Foundation's Integrative Graduate Education and Research Traineeship Fellowship (IGERT). In 2012, he was nominated and appointed as a Faculty Research Fellow to the National Bureau of Economic Research (NBER) program on Productivity, Innovation and Entrepreneurship. To date his research has received over $3 million in funding and support from organization such as the Georgia Research Alliance, Kauffman Foundation, the National Institutes of Health (NIH), National Science Foundation (NSF), Pfizer and IMS Health, Inc.
Currently, Dr. Higgins serves on the Board of Trustees for the Ainsley Paige Higgins Dare-to-Hope Foundation.
Research papers may be accessed at: http://ssrn.com/author=85850
NBER: http://www.nber.org/people/matthew_higgins
Areas of SpecializationEconomics of the pharmaceutical industry Corporate strategy Economic growth and entrepreneurship EducationPhD, Emory University |